Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-r6qrq Total loading time: 0 Render date: 2024-04-29T10:51:56.616Z Has data issue: false hasContentIssue false

Chap 25 - NEUROECTODERMAL TUMORS: MELANOCYTIC, GLIAL, AND MENINGEAL NEOPLASMS

Published online by Cambridge University Press:  01 March 2011

By
Markku Miettinen
Edited by
Markku Miettinen
Markku Miettinen
Affiliation:
Armed Forces Institute of Pathology, Washington DC
Get access

Summary

Although most neuroectodermal tumors are not soft tissue sarcomas, they are important in the differential diagnosis of primary soft tissue tumors. Cutaneous nevi and ordinary cutaneous melanoma are not discussed here, but the reader is referred to other dermatopathology texts such as the Armed Forces Institute of Pathology (AFIP) atlas for melanocytic tumors of the skin. Pigmented neuroectodermal tumor of infancy, extra-central nervous system gliomas, and meningothelial neoplasms relevant to the soft tissues are also discussed. Primitive neuroectodermal tumors belong to the Ewing sarcoma family of tumors and are discussed in Chapter 31.

CELLULAR BLUE NEVUS

The cellular blue nevus (CBN) is a relatively uncommon melanocytic neoplasm that can form a soft tissue mass. It should be distinguished from malignant melanoma and soft tissue sarcoma, especially clear cell sarcoma and malignant peripheral nerve sheath tumor (MPNST). Atypical and malignant forms occur, however, and the latter especially must be distinguished from the indolent variants.

Clinical Features

CBN typically forms a bluish-black cutaneous nodule of 1 cm to 2 cm that can be larger but rarely >5 cm; on occasion the nodule is ulcerated. This tumor often occurs in young adults, occasionally on a congenital basis, and less often in older adults. The average age in the largest series was 33 years, and there was a >2:1 female predominance. Other series have shown an even gender distribution, also with a median age in the early thirties.

Type
Chapter
Information
Modern Soft Tissue Pathology
Tumors and Non-Neoplastic Conditions
 , pp. 724 - 754
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Elder, , Murphy, GF. Melanocytic Tumors of the Skin, third series, fascicle 2. Washington, DC, Armed Forces Institute of Pathology, 1996.Google Scholar
Rodriguez, H, Ackerman, LV. Cellular blue nevus. Cancer 1968;21:393–405.3.0.CO;2-K>CrossRefGoogle ScholarPubMed
Temple-Camp, CR, Saxe, N, King, H. Benign and malignant cellular blue nevus: A clinicopathologic study of 30 cases. Am J Dermatopathol 1988;10:289–296.CrossRefGoogle Scholar
Connelly, J, Smith, JL. Malignant blue nevus. Cancer 1991;67:2653–2657.Google ScholarPubMed
Granter, SR, McKee, PH, Calonje, E, Mihm, MC, Busam, K. Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: A clinicopathologic study of 10 cases of the spectrum of so-called malignant blue nevus. Am J Surg Pathol 2001;25:316–323.CrossRefGoogle Scholar
Zembowicz, A, Granter, SR, McKee, PH, Mihm, MC. Amelanotic cellular blue nevus. A hypopigmented variant of the cellular blue nevus: Clinicopathologic analysis of 20 cases. Am J Surg Pathol 2002;26:1493–1500.CrossRefGoogle ScholarPubMed
Tran, TA, Carlson, JA, Basaca, PC, Mihm, MC. Cellular blue nevus with atypia (atypical cellular blue nevus): a clinicopathologic study of nine cases. J Cutan Pathol 1998;25:252–258.CrossRefGoogle ScholarPubMed
Barnhill, RL, Argenyi, Z, Berwick, M, Duray, PH, Erickson, L, Guitart, J. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma (“malignant blue nevus”). Am J Surg Pathol 2008;32: 36–44.CrossRefGoogle Scholar
Nakhleh, RE, Wick, MR, Rocamora, A, Swanson, PE, Dehner, LP. Morphologic diversity in malignant melanomas. Am J Clin Pathol 1990;93:731–740.CrossRefGoogle ScholarPubMed
Nguyen, NC, Chaar, BT, Osman, MM. Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CT. BMC Med Imaging 2007;7:8.CrossRefGoogle ScholarPubMed
Lodding, P, Kindblom, LG, Angervall, L. Metastases of malignant melanoma simulating soft tissue sarcoma: A clinicopathological, light and electron microscopic and immunohistochemical study of 21 cases. Virchows Arch Pathol Anat Histopathol [A] 1990;417:377–88.CrossRefGoogle Scholar
King, R, Busam, K, Rosai, J: Metastatic malignant melanoma resembling malignant peripheral nerve sheath tumor: report of 16 cases. Am J Surg Pathol 1999;23:1499–505.CrossRefGoogle ScholarPubMed
Gaudin, P, Rosai, J. Florid vascular proliferation associated with neural and neuroendocrine neoplasms: A diagnostic clue and potential pitfall. Am J Surg Pathol 1995;19:642–652.CrossRefGoogle ScholarPubMed
Kaufmann, O, Koch, S, Burghardt, J, Audring, H, Dietel, M. Tyrosinase, melan-A, KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections. Mod Pathol 1998;11:740–746.Google ScholarPubMed
Miettinen, M, Fernandez, M, Franssila, KO, Gataliza, Z, Lasota, J. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma – comparison with four other melanoma markers. Am J Surg Pathol 2001;25:205–211.CrossRefGoogle ScholarPubMed
Zarbo, RJ, Gown, AM, Nagle, RB, Visscher, DW, Crissman, JD. Anomalous cytokeratin expression in malignant melanoma: one- and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas. Mod Pathol 1990;3:494–501.Google ScholarPubMed
Carless, MA, Griffiths, LR. Cytogenetics of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol 2008;624:227–240.CrossRefGoogle ScholarPubMed
Thomas, NE. BRAF somatic mutations in malignant melanoma and melanocytic nevi. Melanoma Res 2006;16:97–103.CrossRefGoogle Scholar
Conley, J, Lattes, R, Orr, W. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer 1971;28:914–936.3.0.CO;2-E>CrossRefGoogle Scholar
Reed, RJ, Leonard, DD. Neurotropic melanoma: A variant of desmoplastic melanoma. Am J Surg Pathol 1979;3:301–311.CrossRefGoogle ScholarPubMed
Reiman, HM, Goellner, JR, Woods, JE, Mixter, RC. Desmoplastic melanoma of the head and neck. Cancer 1987;60:2269–2274.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Egbert, B, Kempson, R, Sagebiel, R. Desmoplastic malignant melanoma: A clinicohistopathologic study of 25 cases. Cancer 1988;62:2033–2041.3.0.CO;2-E>CrossRefGoogle ScholarPubMed
Jain, S, Allen, PW. Desmoplastic malignant melanoma and its variants: A study of 45 cases. Am J Surg Pathol 1989;13:358–373.CrossRefGoogle ScholarPubMed
Smithers, BM, McLeod, GR, Little, JH. Desmoplastic, neural transforming and neurotropic melanoma: a review of 45 cases. Aust N Z J Surg 1990;60:967–972.CrossRefGoogle ScholarPubMed
Carlson, JA, Dickersin, GR, Sober, AJ, Barnhill, RL. Desmoplastic neurotropic melanoma: A clinicopathologic analysis of 28 cases. Cancer 1995;75:478–494.3.0.CO;2-O>CrossRefGoogle ScholarPubMed
Skelton, HG, Smith, KJ, Laskin, WB, McCarthy, WF, Gagnier, JM, Graham, JH, Lupton, GP. Desmoplastic malignant melanoma. J Am Acad Dermatol 1995;32:717–725.CrossRefGoogle ScholarPubMed
Tsao, H, Sober, AJ, Barnhill, RL. Desmoplastic neurotropic melanoma. Semin Cutan Med Surg 1997;16:131–136.CrossRefGoogle ScholarPubMed
Quinn, MJ, Crotty, KA, Thompson, JF, Coates, AS, O'Brien, CJ, McCarthy, WH. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 1998;83:1128–1135.3.0.CO;2-7>CrossRefGoogle ScholarPubMed
Busam, KJ, Mujumdar, U, Hummer, AJ, Nobrega, J, Hawkins, WG, Coit, DG. Cutaneous desmoplastic melanoma: Reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol 2004;28:1518–1525.CrossRefGoogle ScholarPubMed
Busam, KJ. Cutaneous desmoplastic melanoma. Adv Anat Pathol 2005;12:92–102.CrossRefGoogle ScholarPubMed
Kilpatrick, SE, White, WL, Browne, JD. Desmoplastic malignant melanoma of the oral mucosa: An underrecognized diagnostic pitfall. Cancer 1996;78:383–389.3.0.CO;2-L>CrossRefGoogle ScholarPubMed
Su, LD, Fullen, DR, Lowe, L, Wang, TS, Schwartz, JL, Cimmino, WL. Desmoplastic and neurotropic melanoma: Analysis of 33 patients with lymphatic mapping and sentinel lymph node biopsy. Cancer 2004;100:598–604.CrossRefGoogle Scholar
Wharton, JM, Carlson, JA, Mihm, MC. Desmoplastic malignant melanoma: diagnosis of early clinical lesions. Hum Pathol 1999;30:537–542.CrossRefGoogle ScholarPubMed
Longacre, TA, Egbert, BM, Rouse, RV. Desmoplastic and spindle-cell malignant melanoma: An immunohistochemical study. Am J Surg Pathol 1996;20:1489–500.CrossRefGoogle Scholar
Anstey, A, Cerio, R, Ramnarain, N, Orchard, G, Smith, N, Wilson-Jones, E. Desmoplastic malignant melanoma: An immunocytochemical study of 25 cases. Am J Dermatopathol 1994;16:14–22.CrossRefGoogle ScholarPubMed
Koch, MB, Shih, IM, Weiss, SW, Folpe, AL. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics. Am J Surg Pathol 2001;25:58–64.CrossRefGoogle ScholarPubMed
Kanik, AB, Yaar, M, Bhawan, J. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma. J Cutan Pathol 1996;23:205–10.CrossRefGoogle ScholarPubMed
Busam, KJ, Zhao, H, Coit, DG, Kucukgol, D, Jungbluth, AA, Nobrega, J. Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling. J Invest Dermatol 2005;124:412–418.CrossRefGoogle ScholarPubMed
Gutzmer, R, Herbst, RA, Mommert, S, Kiehl, P, Matiaske, F, Rutten, A. Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma. Hum Genet 2000;107:357–61.CrossRefGoogle ScholarPubMed
Enzinger, FM. Clear cell sarcoma of tendons and aponeuroses: an analysis of 21 cases. Cancer 1965;18:1163–1174.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
Peulve, P, Michot, C, Vannier, JP, Tron, P, Hemet, J. Clear cell sarcoma with t(12;22)(q13–14;q12). Genes Chromosomes Cancer 1991;3:400–402.CrossRefGoogle Scholar
Sandberg, AA, Bridge, JA. Updates on the ctogenetic and molecular genetics of bone and soft tissue rumors: clear cell sarcoma (malignant melanoma of soft parts). Cancer Genet Cytogenet 2001;130:1–7.CrossRefGoogle Scholar
Chung, EM, Enzinger, FM. Malignant melanoma of soft parts: reassessment of clear cell sarcoma. Am J Surg Pathol 1983;7:405–413.CrossRefGoogle ScholarPubMed
Kindblom, LG, Lodding, P, Angervall, L. Clear cell sarcoma of tendons and aponeuroses: An immunohistochemical and electron microscopic analysis indicating neural crest origin. Virchows Arch A Pathol Anat Histopathol 1983;401:109–128.CrossRefGoogle ScholarPubMed
Sara, AS, Evans, HL, Benjamin, RS. Malignant melanoma of soft parts (clear cell sarcoma): A study of 17 cases, with emphasis on prognostic factors. Cancer 1990;65:367–374.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Lucas, DR, Nascimento, AG, Sim, FH. Clear cell sarcoma of soft tissues: Mayo Clinic experience with 35 cases. Am J Surg Pathol 1992;16:1197–1204.CrossRefGoogle Scholar
Montgomery, EA, Meis, JM, Ramos, AG, Martz, KL. Clear cell sarcoma of tendons and aponeuroses: A clinicopathologic study of 58 cases with analysis of prognostic factors. Int J Surg Pathol 1993;1:89–100.CrossRefGoogle Scholar
Deenik, W, Mooi, WJ, Rutgers, EJ, Peterse, JL, Hart, AA, Kroon, BB. Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases. Cancer 1999;86:969–975.3.0.CO;2-Z>CrossRefGoogle ScholarPubMed
Ferrari, A, Casanova, M, Bisogno, G, Mattke, A, Meazza, C, Gandola, L. Clear cell sarcoma of tendons and aponeuroses in pediatric patients: report from the Italian and German Soft Tissue Sarcoma Cooperative Group. Cancer 2002;984:3269–3276.CrossRefGoogle Scholar
Coindre, JM, Hostein, I, Terrier, P, Bouvier-Labit, C, Collin, F, Michels, JJ. Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin-embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group. Cancer 2006;107:1055–1064.CrossRefGoogle ScholarPubMed
Kawai, A, Hosono, A, Nakayama, R, Matsumine, A, Matsumoto, S, Ueda, T. Clear cell sarcoma of tendons and aponeuroses: a study of 75 patients. Cancer 2007;109:109–116.CrossRefGoogle ScholarPubMed
Hisaoka, M, Ishda, T, Kuo, TT, Matsuyama, A, Imamura, T, Nishida, K. Clear cell sarcoma of soft tissue: a clinicopathological, immunohistochemical, and molecular analysis of 33 cases. Am J Surg Pathol 2008;32:452–460.CrossRefGoogle Scholar
Rubin, BP, Fletcher, JA, Renshaw, AA. Clear cell sarcoma of soft parts: report of a case primary in the kidney with cytogenetic confirmation. Am J Surg Pathol 1999;23:589–594.CrossRefGoogle ScholarPubMed
Swanson, PE, Wick, MR. Clear cell sarcoma: an immunohistochemical analysis of six cases and comparison with other epithelioid neoplasms of soft tissue. Arch Pathol Lab Med 1989;113:55–60.Google ScholarPubMed
Graadt van Roggen, JF, Mooi, WJ, Hogendoorn, PC. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities. J Pathol 1998;186:3–73.0.CO;2-V>CrossRefGoogle ScholarPubMed
Stenman, G, Kindblom, LG, Angervall, L. Reciprocal translocation t(12;22)(q13;q13) in clear cell sarcoma of tendons and aponeuroses. Genes Chromosomes Cancer 1992;4:122–127.CrossRefGoogle Scholar
Reeves, BR, Fletcher, CD, Gusterson, BA. Translocation t(12;22)(q13;q13) is a nonrandom rearrangement in clear cell sarcoma. Cancer Genet Cytogenet 1992;64:101–103.CrossRefGoogle Scholar
Mrozek, K, Karakousis, CP, Perez-Mesa, C, Bloomfield, CD: Translocation t(12;22)(q13;q12.2–12.3) in a clear cell sarcoma of tendons and aponeuroses. Genes Chromosomes Cancer 1993;6.249–252.CrossRefGoogle Scholar
Fujimura, Y, Ohno, T, Siddique, H, Lee, L, Rao, VN, Reddy, ES. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation encodes a constitutive transcriptional activator. Oncogene 1996;4:159–167.Google Scholar
Pellin, A, Monteagudo, C, Lopez-Gines, C, Carda, C, Boix, J, Llombart-Bosch, A. New type of chimeric fusion product between the EWS and ATFI genes in clear cell sarcoma (malignant melanoma of soft parts). Genes Chromosomes Cancer 1998;23:358–360.3.0.CO;2-3>CrossRefGoogle Scholar
Sonobe, H, Taguchi, T, Shimizu, K, Iwata, J, Furihata, M, Ohtsuki, Y. Further characterization of the human clear cell sarcoma cell line HS-MM demonstrating a specific t(12;22)(q13;q12) translocation and hybrid EWS/ATF-1 transcript. J Pathol 1999;187:594–597.3.0.CO;2-H>CrossRefGoogle Scholar
Bosilevac, JM, Olsen, RJ, Bridge, JA, Hinrichs, SH. Tumor cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein. J Biol Chem 1999;274:34811–34818.CrossRefGoogle ScholarPubMed
Aue, G, Hedges, LK, Schwartz, HS, Bridge, JA, Neff, JR, Butler, MG. Clear cell sarcoma or malignant melanoma of soft parts: molecular analysis of microsatellite instability with clinical correlation. Cancer Genet Cytogenet 1998;105:24–28.CrossRefGoogle ScholarPubMed
Segal, NH, Pavlidis, P, Noble, WS. Classification of clear cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol 2003.21;1775–1781.CrossRefGoogle ScholarPubMed
Langezaal, SM, Graadt van Roggen, JF, Cleton-Jansen, AM, Baelde, JJ, Hogendoorn, PC. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts). Br J Cancer 2001;84:535–538.CrossRefGoogle Scholar
Antonescu, CR, Tschermyavsky, SJ, Woodruff, JM. Molecular diagnosis of clear cell sarcoma: Detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases. J Mol Diagn 2002;4: 44–52.CrossRefGoogle ScholarPubMed
Panagopoulos, I, Mertens, F, Debiec-Rychter, M, Isaksson, M, Limon, J, Kardas, I. Molecular genetic characterization of the EWS/ATF1 fusion gene in cell sarcoma of tendons and aponeuroses. Int J Cancer 2002;99:560–567.CrossRefGoogle ScholarPubMed
HallorK,H K,H, Merrtens, F, Jin, Y, Meis-Kindblom, J, Kindblom, LG, Behrendtz, M. Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer 2005;44:97–102.CrossRefGoogle ScholarPubMed
Patel, RM, Downs-Kelly, F, Weiss, SW, Folpe, AL, Tubbs, RJ, Tuthill, RJ. Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma. Mod Pathol 2005;18:1585–1590.CrossRefGoogle ScholarPubMed
Panagopoulos, I, Mertens, F, Isaksson, M, Mandahl, N. Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses). Cancer Genet Cytogenet 2005:156;74–76.CrossRefGoogle Scholar
Ekfors, TO, Kujari, H, Isomaki, M. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) in the duodenum: the first visceral case. Histopathology 1993;22:255–259.CrossRefGoogle ScholarPubMed
Donner, LR,Trompler, RA, Dobin, S. Clear cell sarcoma of the ileum: the crucial role of cytogenetics for the diagnosis. Am J Surg Pathol 1998;22:121–124.CrossRefGoogle ScholarPubMed
Pauwels, P, Debiec-Rychter, M, Sciot, R, Vlasveld, T, Butter, B, Hagemeijer, A. Clear cell sarcoma of the stomach. Histopathology 2002;41:526–530.CrossRefGoogle ScholarPubMed
Zambrano, E, Reyes-Mugica, M, Franchi, A, Rosai, J. An osteoclast-rich tumor of the gastrointestinal tract with features resembling clear cell sarcoma of soft parts: reports of 6 cases of a GIST simulator. Int J Surg Pathol 2003;11:75–81.CrossRefGoogle ScholarPubMed
Friedrichs, N, Testi, MA, Moiraghi, L, Modena, P, Paggen, E, Plötner, A. Clear cell sarcoma-like tumor with osteoclast-like giant cells in the small bowel: further evidence for a new tumor entity. Int J Surg Pathol 2005;13:313–318.CrossRefGoogle ScholarPubMed
Antonescu, CR, Nafa, K, Segal, NH, Dal Cin, P, Ladanyi, M. EWS-CREB1: a recurrent variant fusion in clear cell sarcoma – association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res 2006;12:5356–5362.CrossRefGoogle ScholarPubMed
Cutler, LS, Chaudry, AP, Topazian, R: Melanotic neuroectodermal tumor of infancy: an ultrastructural study, literature review, and re-evaluation. Cancer 1981;48:257–270.3.0.CO;2-1>CrossRefGoogle Scholar
Johnson, RE, Scheithauer, BW, Dahlin, DC. Melanotic neuroectodermal tumor of infancy: A review of seven cases. Cancer 1983;52:661–666.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Pettinato, G, Manivel, JC, D'Amore, ES, Jaszcz, W, Gorlin, RL. Melanotic neuroectodermal tumor of infancy. A re-examination of a histogenetic problem based on immunohistochemical, flow cytometric, and ultrastructural study of 10 cases. Am J Surg Pathol 1991;15.233–245.CrossRefGoogle Scholar
Kapadia, SB, Frisman, DM, Hitchcock, CL, Ellis, GL, Popek, EJ. Melanotic neuroectodermal tumor of infancy: Clinicopathological, immunohistochemical, and flow cytometric study. Am J Surg Pathol 1993;17:566–573.CrossRefGoogle ScholarPubMed
Pierre-Kahn, A, Cinalli, G, Lellouch-Tubiana, A, Villarejo, FJ, Sainte-Rose, C, Pfister, A. Melanotic neuroectodermal tumor of the skull and meninges in infancy. Pediatr Neurosurg 1992;18.6–15.CrossRefGoogle ScholarPubMed
Yu, JS, Moore, MR, Kupsky, WJ, Scott, RM. Intracranial melanotic neuroectodermal tumor of infancy: two case reports. Surg Neurol 1992;37:123–129.CrossRefGoogle ScholarPubMed
Ricketts, RR, Majmuddar, B. Epididymal melanotic neuroectodermal tumor of infancy. Hum Pathol 1985;16.416–420.CrossRefGoogle ScholarPubMed
Calabrese, F, Danieli, D, Valente, M. Melanotic neuroectodermal tumor of the epididymis in infancy: case report and review of the literature. Urology 1995;46:415–418.CrossRefGoogle ScholarPubMed
Kobayashi, T, Kunimi, K, Imao, T, Ohkawa, M, Komatsu, K, Mizukami, Y. Melanotic neuroectodermal tumor of infancy in the epididymis: Case report and literature review. Urol Int 1996;57:262–265.CrossRefGoogle ScholarPubMed
Raju, U, Zarbo, RJ, Regezi, JA, Krutchkoff, D, Perrin, E: Melanotic neuroectodermal tumor of infancy: intermediate filaments, neuroendocrine and melanoma-associated antigen profiles. Appl Immunohistochem 1993;1:69–76.Google Scholar
Dooling, EC, Chi, JG, Gilles, FH. Melanotic neuroectodermal tumor of infancy: its histological similarities to fetal pineal gland. Cancer 1977;39:1535–1541.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
Navas-Palacios, JJ. Malignant melanotic neuroectodermal tumor: light and electron microscopic study. Cancer 1980;46:529–536.3.0.CO;2-4>CrossRefGoogle ScholarPubMed
Khoddami, M, Squire, J, Zielenska, M, Thorner, P. Melanotic neuroectodermal tumor of infancy: a molecular genetic study. Pediatr Dev Pathol 1998;1:295–299.CrossRefGoogle ScholarPubMed
Hirsh, LF, Stool, SE, Langfitt, RF, Schut, L. Nasal glioma. J Neurosurg 1977;46:85–91.CrossRefGoogle ScholarPubMed
Azumi, N, Matsuno, T, Tateyama, M, Inoue, K. So-called nasal glioma. Acta Pathol Jpn 1984;34:215–220.Google ScholarPubMed
Fletcher, CD, Carpenter, G, McKee, PH. Nasal glioma: A rarity. Am J Dermatopathol 1986;8:341–6.CrossRefGoogle ScholarPubMed
Shepherd, NA, Coates, PJ, Brown, AA. Soft tissue gliomatosis – heterotopic glial tissue in the subcutis: a case report. Histopathology 1987;11:655–60.CrossRefGoogle ScholarPubMed
McDermott, MB, Glasner, SD, Nielsen, PL, Dehner, LP. Soft tissue gliomatosis: Morphologic unity and histogenetic diversity. Am J Surg Pathol 1996;20:148–155.CrossRefGoogle ScholarPubMed
Wolff, M, Santiago, H, Duby, MM. Delayed distant metastasis from a subcutaneous sacrococcygeal myxopapillary ependymoma: Case report, with tissue culture, ultrastructural observations, and review of the literature. Cancer 1972;30:1046–1067.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Helwig, EB, Stern, JB. Subcutaneous sacrococcygeal myxopapillary ependymoma: A clinicopathologic study of 32 cases. Am J Clin Pathol 1984;81:156–161.CrossRefGoogle ScholarPubMed
Kindblom, LG, Lodding, P, Hagmar, B, Stenman, G. Metastasizing myxopapillary ependymoma of the sacrococcygeal region: A clinicopathologic, light- and electron microscopic, immunohistochemical, tissue culture, and cytogenetic analysis of a case. Virchows Arch Pathol Anat Histol 1986;94:79–90.Google Scholar
Sonneland, PR, Scheithauer, BW, Onofrio, BM. Myxopapillary ependymoma: A clinicopathologic and immunocytochemical study of 77 cases. Cancer 1985;56:883–893.3.0.CO;2-6>CrossRefGoogle ScholarPubMed
Pulitzer, DR, Martin, PC, Collins, PC, Ralph, DR. Subcutaneous sacrococcygeal (“myxopapillary”) ependymal rests. Am J Surg Pathol 1988;12:672–677.CrossRefGoogle ScholarPubMed
Sawyer, JR, Miller, JP, Ellison, DA. Clonal telomeric fusions and chromosome instability in a subcutaneous sacrococcygeal myxopapillary ependymoma. Cancer Genet Cytogenet 1998;100:169–175.CrossRefGoogle Scholar
Bell, DA, Woodruff, JM, Scully, RE. Ependymoma of the broad ligament. Am J Surg Pathol 1984;8:203–209.CrossRefGoogle ScholarPubMed
Duggan, MA, Hugh, J, Nation, JG, Robertson, DI, Stuart, GCE. Ependymoma of the uterosacral ligament. Cancer 1989;64:2565–2571.3.0.CO;2-I>CrossRefGoogle ScholarPubMed
Kleinman, GM, Young, RH, Scully, RE. Ependymoma of the ovary: Report of three cases. Hum Pathol 1984;15:632–638.CrossRefGoogle ScholarPubMed
Idowu, MO, Rosenblum, MK, Wei, XJ, Edgar, MA, Soslow, RA. Ependymomas of the central nervous system and adult extra-axial ependymomas are morphologically and immunohistochemically distinct – A comparative study with assessment of ovarian carcinomas for expression of glial fibrillary protein. Am J Surg Pathol 2008;32:710–718.CrossRefGoogle Scholar
Newton, HB, Henson, J, Walker, RW. Extraneural metastases in ependymoma. J Neuro-oncol 1992;14:135–142.CrossRefGoogle ScholarPubMed
Nobles, E, Lee, R, Kircher, T. Mediastinal ependymoma. Hum Pathol 1991;22:94–96.CrossRefGoogle ScholarPubMed
Wilson, RW, Moran, CA. Primary ependymoma of the mediastinum: a clinicopathologic study of three cases. Ann Diagn Pathol 1998;2:293–300.CrossRefGoogle ScholarPubMed
Lopez, DA, Silvers, DN, Helwig, EB. Cutaneous meningiomas – a clinicopathologic study. Cancer 1974;34:728–744.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Rogers, GF, Mulliken, JB, Kozakewich, HPW. Heterotopic neural nodules of the scalp. Plast Reconstr Surg 2005;115: 376–382.CrossRefGoogle ScholarPubMed
Sibley, DA, Cooper, PH. Rudimentary meningocele: a variant of “primary cutaneous meningioma.” J Cutan Pathol 1989;16:72–80.CrossRefGoogle Scholar
Argenyi, ZB. Cutaneous neural heterotopias and related tumors relevant for the dermatopathologist. Semin Diagn Pathol 1996;13:60–71.Google ScholarPubMed
Argenyi, ZB, Thieberg, MD, Hayes, CM, Whitaker, DC. Primary cutaneous meningioma associated with von Recklinghausen's disease. J Cutan Pathol 1994;21:549–556.CrossRefGoogle ScholarPubMed
Miyamoto, T, Mihara, M, Hagari, Y, Shimao, S. Primary cutaneous meningioma on the scalp: report of two siblings. J Dermatol 1995;22:611–619.CrossRefGoogle ScholarPubMed
Suster, S, Rosai, J. Hamartoma of the scalp with meningothelial elements: A distinctive benign soft tissue lesion that may simulate angiosarcoma. Am J Surg Pathol 1990;14.1–11.CrossRefGoogle ScholarPubMed
Theaker, JM, Fletcher, CD, Tudway, AJ. Cutaneous heterotopic meningeal nodules. Histopathology 1990;16:475–479.CrossRefGoogle ScholarPubMed
Gelli, MC, Pasquinelli, G, Martinelli, G, Gardini, G. Cutaneous meningioma: histochemical, immunohistochemical and ultrastructural investigation. Histopathology 1993; 23:576–578.CrossRefGoogle ScholarPubMed
Perzin, KH, Pushparaj, N. Nonepithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx. A clinicopathologic study. XIII: meningiomas. Cancer 1984;54:1860–1869.3.0.CO;2-9>CrossRefGoogle ScholarPubMed
Thompson, LD, Guyre, K. Extracranial sinonasal tract meningiomas: a clinicopathologic study of 30 cases with a review of the literature. Am J Surg Pathol 2000;24:640–650.CrossRefGoogle ScholarPubMed
Johnson, TE, Weatherhead, RG, Nasr, Am, Siqueira, EB. Ectopic (extradural) meningioma of the orbit: report of two cases in children. J Pediatr Opththalmol Strabismus 19993;30:43–47.Google Scholar
Kuhn, C, Askin, FB. The fine structure of so-called minute pulmonary chemodectomas. Hum Pathol 1975;6:681–691.CrossRefGoogle ScholarPubMed
Gaffey, MJ, Mills, SE, Askin, FB. Minute pulmonary meningothelial-like nodules: A clinicopathologic study of the so-called minute pulmonary chemodectoma. Am J Surg Pathol 1988;12.167–175.CrossRefGoogle ScholarPubMed
Niho, S, Yokose, T, Nishiwaki, Y, Mukai, K. Immunohistochemical and clonal analysis of minute pulmonary meningothelial-like nodules. Hum Pathol 1999.30:425–429.CrossRefGoogle ScholarPubMed
Suster, S, Moran, C. Diffuse pulmonary meningotheliomatosis. Am J Surg Pathol 2007;31:624–631.CrossRefGoogle ScholarPubMed
Williamson, BE, Stanton, CA, Levine, EA. Chest wall metastasis from recurrent meningioma. Am Surg 2001;67:966–968.Google ScholarPubMed
Sadahira, Y, Sugihara, K, Manabe, T. Iatrogenic implantation of malignant meningioma to the abdominal wall. Virchows Arch 2001;438:316–318.Google ScholarPubMed
Ozer, E, Kalemei, O, Acar, UD, Canda, S. Pin site metastasis of meningioma. Br J Neurosurg 2007;21:524–527.CrossRefGoogle ScholarPubMed
Elder, , Murphy, GF. Melanocytic Tumors of the Skin, third series, fascicle 2. Washington, DC, Armed Forces Institute of Pathology, 1996.Google Scholar
Rodriguez, H, Ackerman, LV. Cellular blue nevus. Cancer 1968;21:393–405.3.0.CO;2-K>CrossRefGoogle ScholarPubMed
Temple-Camp, CR, Saxe, N, King, H. Benign and malignant cellular blue nevus: A clinicopathologic study of 30 cases. Am J Dermatopathol 1988;10:289–296.CrossRefGoogle Scholar
Connelly, J, Smith, JL. Malignant blue nevus. Cancer 1991;67:2653–2657.Google ScholarPubMed
Granter, SR, McKee, PH, Calonje, E, Mihm, MC, Busam, K. Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: A clinicopathologic study of 10 cases of the spectrum of so-called malignant blue nevus. Am J Surg Pathol 2001;25:316–323.CrossRefGoogle Scholar
Zembowicz, A, Granter, SR, McKee, PH, Mihm, MC. Amelanotic cellular blue nevus. A hypopigmented variant of the cellular blue nevus: Clinicopathologic analysis of 20 cases. Am J Surg Pathol 2002;26:1493–1500.CrossRefGoogle ScholarPubMed
Tran, TA, Carlson, JA, Basaca, PC, Mihm, MC. Cellular blue nevus with atypia (atypical cellular blue nevus): a clinicopathologic study of nine cases. J Cutan Pathol 1998;25:252–258.CrossRefGoogle ScholarPubMed
Barnhill, RL, Argenyi, Z, Berwick, M, Duray, PH, Erickson, L, Guitart, J. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma (“malignant blue nevus”). Am J Surg Pathol 2008;32: 36–44.CrossRefGoogle Scholar
Nakhleh, RE, Wick, MR, Rocamora, A, Swanson, PE, Dehner, LP. Morphologic diversity in malignant melanomas. Am J Clin Pathol 1990;93:731–740.CrossRefGoogle ScholarPubMed
Nguyen, NC, Chaar, BT, Osman, MM. Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CT. BMC Med Imaging 2007;7:8.CrossRefGoogle ScholarPubMed
Lodding, P, Kindblom, LG, Angervall, L. Metastases of malignant melanoma simulating soft tissue sarcoma: A clinicopathological, light and electron microscopic and immunohistochemical study of 21 cases. Virchows Arch Pathol Anat Histopathol [A] 1990;417:377–88.CrossRefGoogle Scholar
King, R, Busam, K, Rosai, J: Metastatic malignant melanoma resembling malignant peripheral nerve sheath tumor: report of 16 cases. Am J Surg Pathol 1999;23:1499–505.CrossRefGoogle ScholarPubMed
Gaudin, P, Rosai, J. Florid vascular proliferation associated with neural and neuroendocrine neoplasms: A diagnostic clue and potential pitfall. Am J Surg Pathol 1995;19:642–652.CrossRefGoogle ScholarPubMed
Kaufmann, O, Koch, S, Burghardt, J, Audring, H, Dietel, M. Tyrosinase, melan-A, KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections. Mod Pathol 1998;11:740–746.Google ScholarPubMed
Miettinen, M, Fernandez, M, Franssila, KO, Gataliza, Z, Lasota, J. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma – comparison with four other melanoma markers. Am J Surg Pathol 2001;25:205–211.CrossRefGoogle ScholarPubMed
Zarbo, RJ, Gown, AM, Nagle, RB, Visscher, DW, Crissman, JD. Anomalous cytokeratin expression in malignant melanoma: one- and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas. Mod Pathol 1990;3:494–501.Google ScholarPubMed
Carless, MA, Griffiths, LR. Cytogenetics of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol 2008;624:227–240.CrossRefGoogle ScholarPubMed
Thomas, NE. BRAF somatic mutations in malignant melanoma and melanocytic nevi. Melanoma Res 2006;16:97–103.CrossRefGoogle Scholar
Conley, J, Lattes, R, Orr, W. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer 1971;28:914–936.3.0.CO;2-E>CrossRefGoogle Scholar
Reed, RJ, Leonard, DD. Neurotropic melanoma: A variant of desmoplastic melanoma. Am J Surg Pathol 1979;3:301–311.CrossRefGoogle ScholarPubMed
Reiman, HM, Goellner, JR, Woods, JE, Mixter, RC. Desmoplastic melanoma of the head and neck. Cancer 1987;60:2269–2274.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Egbert, B, Kempson, R, Sagebiel, R. Desmoplastic malignant melanoma: A clinicohistopathologic study of 25 cases. Cancer 1988;62:2033–2041.3.0.CO;2-E>CrossRefGoogle ScholarPubMed
Jain, S, Allen, PW. Desmoplastic malignant melanoma and its variants: A study of 45 cases. Am J Surg Pathol 1989;13:358–373.CrossRefGoogle ScholarPubMed
Smithers, BM, McLeod, GR, Little, JH. Desmoplastic, neural transforming and neurotropic melanoma: a review of 45 cases. Aust N Z J Surg 1990;60:967–972.CrossRefGoogle ScholarPubMed
Carlson, JA, Dickersin, GR, Sober, AJ, Barnhill, RL. Desmoplastic neurotropic melanoma: A clinicopathologic analysis of 28 cases. Cancer 1995;75:478–494.3.0.CO;2-O>CrossRefGoogle ScholarPubMed
Skelton, HG, Smith, KJ, Laskin, WB, McCarthy, WF, Gagnier, JM, Graham, JH, Lupton, GP. Desmoplastic malignant melanoma. J Am Acad Dermatol 1995;32:717–725.CrossRefGoogle ScholarPubMed
Tsao, H, Sober, AJ, Barnhill, RL. Desmoplastic neurotropic melanoma. Semin Cutan Med Surg 1997;16:131–136.CrossRefGoogle ScholarPubMed
Quinn, MJ, Crotty, KA, Thompson, JF, Coates, AS, O'Brien, CJ, McCarthy, WH. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 1998;83:1128–1135.3.0.CO;2-7>CrossRefGoogle ScholarPubMed
Busam, KJ, Mujumdar, U, Hummer, AJ, Nobrega, J, Hawkins, WG, Coit, DG. Cutaneous desmoplastic melanoma: Reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol 2004;28:1518–1525.CrossRefGoogle ScholarPubMed
Busam, KJ. Cutaneous desmoplastic melanoma. Adv Anat Pathol 2005;12:92–102.CrossRefGoogle ScholarPubMed
Kilpatrick, SE, White, WL, Browne, JD. Desmoplastic malignant melanoma of the oral mucosa: An underrecognized diagnostic pitfall. Cancer 1996;78:383–389.3.0.CO;2-L>CrossRefGoogle ScholarPubMed
Su, LD, Fullen, DR, Lowe, L, Wang, TS, Schwartz, JL, Cimmino, WL. Desmoplastic and neurotropic melanoma: Analysis of 33 patients with lymphatic mapping and sentinel lymph node biopsy. Cancer 2004;100:598–604.CrossRefGoogle Scholar
Wharton, JM, Carlson, JA, Mihm, MC. Desmoplastic malignant melanoma: diagnosis of early clinical lesions. Hum Pathol 1999;30:537–542.CrossRefGoogle ScholarPubMed
Longacre, TA, Egbert, BM, Rouse, RV. Desmoplastic and spindle-cell malignant melanoma: An immunohistochemical study. Am J Surg Pathol 1996;20:1489–500.CrossRefGoogle Scholar
Anstey, A, Cerio, R, Ramnarain, N, Orchard, G, Smith, N, Wilson-Jones, E. Desmoplastic malignant melanoma: An immunocytochemical study of 25 cases. Am J Dermatopathol 1994;16:14–22.CrossRefGoogle ScholarPubMed
Koch, MB, Shih, IM, Weiss, SW, Folpe, AL. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics. Am J Surg Pathol 2001;25:58–64.CrossRefGoogle ScholarPubMed
Kanik, AB, Yaar, M, Bhawan, J. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma. J Cutan Pathol 1996;23:205–10.CrossRefGoogle ScholarPubMed
Busam, KJ, Zhao, H, Coit, DG, Kucukgol, D, Jungbluth, AA, Nobrega, J. Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling. J Invest Dermatol 2005;124:412–418.CrossRefGoogle ScholarPubMed
Gutzmer, R, Herbst, RA, Mommert, S, Kiehl, P, Matiaske, F, Rutten, A. Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma. Hum Genet 2000;107:357–61.CrossRefGoogle ScholarPubMed
Enzinger, FM. Clear cell sarcoma of tendons and aponeuroses: an analysis of 21 cases. Cancer 1965;18:1163–1174.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
Peulve, P, Michot, C, Vannier, JP, Tron, P, Hemet, J. Clear cell sarcoma with t(12;22)(q13–14;q12). Genes Chromosomes Cancer 1991;3:400–402.CrossRefGoogle Scholar
Sandberg, AA, Bridge, JA. Updates on the ctogenetic and molecular genetics of bone and soft tissue rumors: clear cell sarcoma (malignant melanoma of soft parts). Cancer Genet Cytogenet 2001;130:1–7.CrossRefGoogle Scholar
Chung, EM, Enzinger, FM. Malignant melanoma of soft parts: reassessment of clear cell sarcoma. Am J Surg Pathol 1983;7:405–413.CrossRefGoogle ScholarPubMed
Kindblom, LG, Lodding, P, Angervall, L. Clear cell sarcoma of tendons and aponeuroses: An immunohistochemical and electron microscopic analysis indicating neural crest origin. Virchows Arch A Pathol Anat Histopathol 1983;401:109–128.CrossRefGoogle ScholarPubMed
Sara, AS, Evans, HL, Benjamin, RS. Malignant melanoma of soft parts (clear cell sarcoma): A study of 17 cases, with emphasis on prognostic factors. Cancer 1990;65:367–374.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Lucas, DR, Nascimento, AG, Sim, FH. Clear cell sarcoma of soft tissues: Mayo Clinic experience with 35 cases. Am J Surg Pathol 1992;16:1197–1204.CrossRefGoogle Scholar
Montgomery, EA, Meis, JM, Ramos, AG, Martz, KL. Clear cell sarcoma of tendons and aponeuroses: A clinicopathologic study of 58 cases with analysis of prognostic factors. Int J Surg Pathol 1993;1:89–100.CrossRefGoogle Scholar
Deenik, W, Mooi, WJ, Rutgers, EJ, Peterse, JL, Hart, AA, Kroon, BB. Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases. Cancer 1999;86:969–975.3.0.CO;2-Z>CrossRefGoogle ScholarPubMed
Ferrari, A, Casanova, M, Bisogno, G, Mattke, A, Meazza, C, Gandola, L. Clear cell sarcoma of tendons and aponeuroses in pediatric patients: report from the Italian and German Soft Tissue Sarcoma Cooperative Group. Cancer 2002;984:3269–3276.CrossRefGoogle Scholar
Coindre, JM, Hostein, I, Terrier, P, Bouvier-Labit, C, Collin, F, Michels, JJ. Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin-embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group. Cancer 2006;107:1055–1064.CrossRefGoogle ScholarPubMed
Kawai, A, Hosono, A, Nakayama, R, Matsumine, A, Matsumoto, S, Ueda, T. Clear cell sarcoma of tendons and aponeuroses: a study of 75 patients. Cancer 2007;109:109–116.CrossRefGoogle ScholarPubMed
Hisaoka, M, Ishda, T, Kuo, TT, Matsuyama, A, Imamura, T, Nishida, K. Clear cell sarcoma of soft tissue: a clinicopathological, immunohistochemical, and molecular analysis of 33 cases. Am J Surg Pathol 2008;32:452–460.CrossRefGoogle Scholar
Rubin, BP, Fletcher, JA, Renshaw, AA. Clear cell sarcoma of soft parts: report of a case primary in the kidney with cytogenetic confirmation. Am J Surg Pathol 1999;23:589–594.CrossRefGoogle ScholarPubMed
Swanson, PE, Wick, MR. Clear cell sarcoma: an immunohistochemical analysis of six cases and comparison with other epithelioid neoplasms of soft tissue. Arch Pathol Lab Med 1989;113:55–60.Google ScholarPubMed
Graadt van Roggen, JF, Mooi, WJ, Hogendoorn, PC. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities. J Pathol 1998;186:3–73.0.CO;2-V>CrossRefGoogle ScholarPubMed
Stenman, G, Kindblom, LG, Angervall, L. Reciprocal translocation t(12;22)(q13;q13) in clear cell sarcoma of tendons and aponeuroses. Genes Chromosomes Cancer 1992;4:122–127.CrossRefGoogle Scholar
Reeves, BR, Fletcher, CD, Gusterson, BA. Translocation t(12;22)(q13;q13) is a nonrandom rearrangement in clear cell sarcoma. Cancer Genet Cytogenet 1992;64:101–103.CrossRefGoogle Scholar
Mrozek, K, Karakousis, CP, Perez-Mesa, C, Bloomfield, CD: Translocation t(12;22)(q13;q12.2–12.3) in a clear cell sarcoma of tendons and aponeuroses. Genes Chromosomes Cancer 1993;6.249–252.CrossRefGoogle Scholar
Fujimura, Y, Ohno, T, Siddique, H, Lee, L, Rao, VN, Reddy, ES. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation encodes a constitutive transcriptional activator. Oncogene 1996;4:159–167.Google Scholar
Pellin, A, Monteagudo, C, Lopez-Gines, C, Carda, C, Boix, J, Llombart-Bosch, A. New type of chimeric fusion product between the EWS and ATFI genes in clear cell sarcoma (malignant melanoma of soft parts). Genes Chromosomes Cancer 1998;23:358–360.3.0.CO;2-3>CrossRefGoogle Scholar
Sonobe, H, Taguchi, T, Shimizu, K, Iwata, J, Furihata, M, Ohtsuki, Y. Further characterization of the human clear cell sarcoma cell line HS-MM demonstrating a specific t(12;22)(q13;q12) translocation and hybrid EWS/ATF-1 transcript. J Pathol 1999;187:594–597.3.0.CO;2-H>CrossRefGoogle Scholar
Bosilevac, JM, Olsen, RJ, Bridge, JA, Hinrichs, SH. Tumor cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein. J Biol Chem 1999;274:34811–34818.CrossRefGoogle ScholarPubMed
Aue, G, Hedges, LK, Schwartz, HS, Bridge, JA, Neff, JR, Butler, MG. Clear cell sarcoma or malignant melanoma of soft parts: molecular analysis of microsatellite instability with clinical correlation. Cancer Genet Cytogenet 1998;105:24–28.CrossRefGoogle ScholarPubMed
Segal, NH, Pavlidis, P, Noble, WS. Classification of clear cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol 2003.21;1775–1781.CrossRefGoogle ScholarPubMed
Langezaal, SM, Graadt van Roggen, JF, Cleton-Jansen, AM, Baelde, JJ, Hogendoorn, PC. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts). Br J Cancer 2001;84:535–538.CrossRefGoogle Scholar
Antonescu, CR, Tschermyavsky, SJ, Woodruff, JM. Molecular diagnosis of clear cell sarcoma: Detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases. J Mol Diagn 2002;4: 44–52.CrossRefGoogle ScholarPubMed
Panagopoulos, I, Mertens, F, Debiec-Rychter, M, Isaksson, M, Limon, J, Kardas, I. Molecular genetic characterization of the EWS/ATF1 fusion gene in cell sarcoma of tendons and aponeuroses. Int J Cancer 2002;99:560–567.CrossRefGoogle ScholarPubMed
HallorK,H K,H, Merrtens, F, Jin, Y, Meis-Kindblom, J, Kindblom, LG, Behrendtz, M. Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer 2005;44:97–102.CrossRefGoogle ScholarPubMed
Patel, RM, Downs-Kelly, F, Weiss, SW, Folpe, AL, Tubbs, RJ, Tuthill, RJ. Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma. Mod Pathol 2005;18:1585–1590.CrossRefGoogle ScholarPubMed
Panagopoulos, I, Mertens, F, Isaksson, M, Mandahl, N. Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses). Cancer Genet Cytogenet 2005:156;74–76.CrossRefGoogle Scholar
Ekfors, TO, Kujari, H, Isomaki, M. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) in the duodenum: the first visceral case. Histopathology 1993;22:255–259.CrossRefGoogle ScholarPubMed
Donner, LR,Trompler, RA, Dobin, S. Clear cell sarcoma of the ileum: the crucial role of cytogenetics for the diagnosis. Am J Surg Pathol 1998;22:121–124.CrossRefGoogle ScholarPubMed
Pauwels, P, Debiec-Rychter, M, Sciot, R, Vlasveld, T, Butter, B, Hagemeijer, A. Clear cell sarcoma of the stomach. Histopathology 2002;41:526–530.CrossRefGoogle ScholarPubMed
Zambrano, E, Reyes-Mugica, M, Franchi, A, Rosai, J. An osteoclast-rich tumor of the gastrointestinal tract with features resembling clear cell sarcoma of soft parts: reports of 6 cases of a GIST simulator. Int J Surg Pathol 2003;11:75–81.CrossRefGoogle ScholarPubMed
Friedrichs, N, Testi, MA, Moiraghi, L, Modena, P, Paggen, E, Plötner, A. Clear cell sarcoma-like tumor with osteoclast-like giant cells in the small bowel: further evidence for a new tumor entity. Int J Surg Pathol 2005;13:313–318.CrossRefGoogle ScholarPubMed
Antonescu, CR, Nafa, K, Segal, NH, Dal Cin, P, Ladanyi, M. EWS-CREB1: a recurrent variant fusion in clear cell sarcoma – association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res 2006;12:5356–5362.CrossRefGoogle ScholarPubMed
Cutler, LS, Chaudry, AP, Topazian, R: Melanotic neuroectodermal tumor of infancy: an ultrastructural study, literature review, and re-evaluation. Cancer 1981;48:257–270.3.0.CO;2-1>CrossRefGoogle Scholar
Johnson, RE, Scheithauer, BW, Dahlin, DC. Melanotic neuroectodermal tumor of infancy: A review of seven cases. Cancer 1983;52:661–666.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Pettinato, G, Manivel, JC, D'Amore, ES, Jaszcz, W, Gorlin, RL. Melanotic neuroectodermal tumor of infancy. A re-examination of a histogenetic problem based on immunohistochemical, flow cytometric, and ultrastructural study of 10 cases. Am J Surg Pathol 1991;15.233–245.CrossRefGoogle Scholar
Kapadia, SB, Frisman, DM, Hitchcock, CL, Ellis, GL, Popek, EJ. Melanotic neuroectodermal tumor of infancy: Clinicopathological, immunohistochemical, and flow cytometric study. Am J Surg Pathol 1993;17:566–573.CrossRefGoogle ScholarPubMed
Pierre-Kahn, A, Cinalli, G, Lellouch-Tubiana, A, Villarejo, FJ, Sainte-Rose, C, Pfister, A. Melanotic neuroectodermal tumor of the skull and meninges in infancy. Pediatr Neurosurg 1992;18.6–15.CrossRefGoogle ScholarPubMed
Yu, JS, Moore, MR, Kupsky, WJ, Scott, RM. Intracranial melanotic neuroectodermal tumor of infancy: two case reports. Surg Neurol 1992;37:123–129.CrossRefGoogle ScholarPubMed
Ricketts, RR, Majmuddar, B. Epididymal melanotic neuroectodermal tumor of infancy. Hum Pathol 1985;16.416–420.CrossRefGoogle ScholarPubMed
Calabrese, F, Danieli, D, Valente, M. Melanotic neuroectodermal tumor of the epididymis in infancy: case report and review of the literature. Urology 1995;46:415–418.CrossRefGoogle ScholarPubMed
Kobayashi, T, Kunimi, K, Imao, T, Ohkawa, M, Komatsu, K, Mizukami, Y. Melanotic neuroectodermal tumor of infancy in the epididymis: Case report and literature review. Urol Int 1996;57:262–265.CrossRefGoogle ScholarPubMed
Raju, U, Zarbo, RJ, Regezi, JA, Krutchkoff, D, Perrin, E: Melanotic neuroectodermal tumor of infancy: intermediate filaments, neuroendocrine and melanoma-associated antigen profiles. Appl Immunohistochem 1993;1:69–76.Google Scholar
Dooling, EC, Chi, JG, Gilles, FH. Melanotic neuroectodermal tumor of infancy: its histological similarities to fetal pineal gland. Cancer 1977;39:1535–1541.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
Navas-Palacios, JJ. Malignant melanotic neuroectodermal tumor: light and electron microscopic study. Cancer 1980;46:529–536.3.0.CO;2-4>CrossRefGoogle ScholarPubMed
Khoddami, M, Squire, J, Zielenska, M, Thorner, P. Melanotic neuroectodermal tumor of infancy: a molecular genetic study. Pediatr Dev Pathol 1998;1:295–299.CrossRefGoogle ScholarPubMed
Hirsh, LF, Stool, SE, Langfitt, RF, Schut, L. Nasal glioma. J Neurosurg 1977;46:85–91.CrossRefGoogle ScholarPubMed
Azumi, N, Matsuno, T, Tateyama, M, Inoue, K. So-called nasal glioma. Acta Pathol Jpn 1984;34:215–220.Google ScholarPubMed
Fletcher, CD, Carpenter, G, McKee, PH. Nasal glioma: A rarity. Am J Dermatopathol 1986;8:341–6.CrossRefGoogle ScholarPubMed
Shepherd, NA, Coates, PJ, Brown, AA. Soft tissue gliomatosis – heterotopic glial tissue in the subcutis: a case report. Histopathology 1987;11:655–60.CrossRefGoogle ScholarPubMed
McDermott, MB, Glasner, SD, Nielsen, PL, Dehner, LP. Soft tissue gliomatosis: Morphologic unity and histogenetic diversity. Am J Surg Pathol 1996;20:148–155.CrossRefGoogle ScholarPubMed
Wolff, M, Santiago, H, Duby, MM. Delayed distant metastasis from a subcutaneous sacrococcygeal myxopapillary ependymoma: Case report, with tissue culture, ultrastructural observations, and review of the literature. Cancer 1972;30:1046–1067.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Helwig, EB, Stern, JB. Subcutaneous sacrococcygeal myxopapillary ependymoma: A clinicopathologic study of 32 cases. Am J Clin Pathol 1984;81:156–161.CrossRefGoogle ScholarPubMed
Kindblom, LG, Lodding, P, Hagmar, B, Stenman, G. Metastasizing myxopapillary ependymoma of the sacrococcygeal region: A clinicopathologic, light- and electron microscopic, immunohistochemical, tissue culture, and cytogenetic analysis of a case. Virchows Arch Pathol Anat Histol 1986;94:79–90.Google Scholar
Sonneland, PR, Scheithauer, BW, Onofrio, BM. Myxopapillary ependymoma: A clinicopathologic and immunocytochemical study of 77 cases. Cancer 1985;56:883–893.3.0.CO;2-6>CrossRefGoogle ScholarPubMed
Pulitzer, DR, Martin, PC, Collins, PC, Ralph, DR. Subcutaneous sacrococcygeal (“myxopapillary”) ependymal rests. Am J Surg Pathol 1988;12:672–677.CrossRefGoogle ScholarPubMed
Sawyer, JR, Miller, JP, Ellison, DA. Clonal telomeric fusions and chromosome instability in a subcutaneous sacrococcygeal myxopapillary ependymoma. Cancer Genet Cytogenet 1998;100:169–175.CrossRefGoogle Scholar
Bell, DA, Woodruff, JM, Scully, RE. Ependymoma of the broad ligament. Am J Surg Pathol 1984;8:203–209.CrossRefGoogle ScholarPubMed
Duggan, MA, Hugh, J, Nation, JG, Robertson, DI, Stuart, GCE. Ependymoma of the uterosacral ligament. Cancer 1989;64:2565–2571.3.0.CO;2-I>CrossRefGoogle ScholarPubMed
Kleinman, GM, Young, RH, Scully, RE. Ependymoma of the ovary: Report of three cases. Hum Pathol 1984;15:632–638.CrossRefGoogle ScholarPubMed
Idowu, MO, Rosenblum, MK, Wei, XJ, Edgar, MA, Soslow, RA. Ependymomas of the central nervous system and adult extra-axial ependymomas are morphologically and immunohistochemically distinct – A comparative study with assessment of ovarian carcinomas for expression of glial fibrillary protein. Am J Surg Pathol 2008;32:710–718.CrossRefGoogle Scholar
Newton, HB, Henson, J, Walker, RW. Extraneural metastases in ependymoma. J Neuro-oncol 1992;14:135–142.CrossRefGoogle ScholarPubMed
Nobles, E, Lee, R, Kircher, T. Mediastinal ependymoma. Hum Pathol 1991;22:94–96.CrossRefGoogle ScholarPubMed
Wilson, RW, Moran, CA. Primary ependymoma of the mediastinum: a clinicopathologic study of three cases. Ann Diagn Pathol 1998;2:293–300.CrossRefGoogle ScholarPubMed
Lopez, DA, Silvers, DN, Helwig, EB. Cutaneous meningiomas – a clinicopathologic study. Cancer 1974;34:728–744.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Rogers, GF, Mulliken, JB, Kozakewich, HPW. Heterotopic neural nodules of the scalp. Plast Reconstr Surg 2005;115: 376–382.CrossRefGoogle ScholarPubMed
Sibley, DA, Cooper, PH. Rudimentary meningocele: a variant of “primary cutaneous meningioma.” J Cutan Pathol 1989;16:72–80.CrossRefGoogle Scholar
Argenyi, ZB. Cutaneous neural heterotopias and related tumors relevant for the dermatopathologist. Semin Diagn Pathol 1996;13:60–71.Google ScholarPubMed
Argenyi, ZB, Thieberg, MD, Hayes, CM, Whitaker, DC. Primary cutaneous meningioma associated with von Recklinghausen's disease. J Cutan Pathol 1994;21:549–556.CrossRefGoogle ScholarPubMed
Miyamoto, T, Mihara, M, Hagari, Y, Shimao, S. Primary cutaneous meningioma on the scalp: report of two siblings. J Dermatol 1995;22:611–619.CrossRefGoogle ScholarPubMed
Suster, S, Rosai, J. Hamartoma of the scalp with meningothelial elements: A distinctive benign soft tissue lesion that may simulate angiosarcoma. Am J Surg Pathol 1990;14.1–11.CrossRefGoogle ScholarPubMed
Theaker, JM, Fletcher, CD, Tudway, AJ. Cutaneous heterotopic meningeal nodules. Histopathology 1990;16:475–479.CrossRefGoogle ScholarPubMed
Gelli, MC, Pasquinelli, G, Martinelli, G, Gardini, G. Cutaneous meningioma: histochemical, immunohistochemical and ultrastructural investigation. Histopathology 1993; 23:576–578.CrossRefGoogle ScholarPubMed
Perzin, KH, Pushparaj, N. Nonepithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx. A clinicopathologic study. XIII: meningiomas. Cancer 1984;54:1860–1869.3.0.CO;2-9>CrossRefGoogle ScholarPubMed
Thompson, LD, Guyre, K. Extracranial sinonasal tract meningiomas: a clinicopathologic study of 30 cases with a review of the literature. Am J Surg Pathol 2000;24:640–650.CrossRefGoogle ScholarPubMed
Johnson, TE, Weatherhead, RG, Nasr, Am, Siqueira, EB. Ectopic (extradural) meningioma of the orbit: report of two cases in children. J Pediatr Opththalmol Strabismus 19993;30:43–47.Google Scholar
Kuhn, C, Askin, FB. The fine structure of so-called minute pulmonary chemodectomas. Hum Pathol 1975;6:681–691.CrossRefGoogle ScholarPubMed
Gaffey, MJ, Mills, SE, Askin, FB. Minute pulmonary meningothelial-like nodules: A clinicopathologic study of the so-called minute pulmonary chemodectoma. Am J Surg Pathol 1988;12.167–175.CrossRefGoogle ScholarPubMed
Niho, S, Yokose, T, Nishiwaki, Y, Mukai, K. Immunohistochemical and clonal analysis of minute pulmonary meningothelial-like nodules. Hum Pathol 1999.30:425–429.CrossRefGoogle ScholarPubMed
Suster, S, Moran, C. Diffuse pulmonary meningotheliomatosis. Am J Surg Pathol 2007;31:624–631.CrossRefGoogle ScholarPubMed
Williamson, BE, Stanton, CA, Levine, EA. Chest wall metastasis from recurrent meningioma. Am Surg 2001;67:966–968.Google ScholarPubMed
Sadahira, Y, Sugihara, K, Manabe, T. Iatrogenic implantation of malignant meningioma to the abdominal wall. Virchows Arch 2001;438:316–318.Google ScholarPubMed
Ozer, E, Kalemei, O, Acar, UD, Canda, S. Pin site metastasis of meningioma. Br J Neurosurg 2007;21:524–527.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×